MD345G2 - Method of calves bacteriosis treatment - Google Patents

Method of calves bacteriosis treatment

Info

Publication number
MD345G2
MD345G2 MD95-0231A MD950231A MD345G2 MD 345 G2 MD345 G2 MD 345G2 MD 950231 A MD950231 A MD 950231A MD 345 G2 MD345 G2 MD 345G2
Authority
MD
Moldova
Prior art keywords
treatment
doze
utilization
injected
days
Prior art date
Application number
MD95-0231A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD345F1 (en
Inventor
Nicolae Josan
Original Assignee
Государственный аграрный университет Молдовы
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный аграрный университет Молдовы filed Critical Государственный аграрный университет Молдовы
Priority to MD95-0231A priority Critical patent/MD345G2/en
Publication of MD345F1 publication Critical patent/MD345F1/en
Publication of MD345G2 publication Critical patent/MD345G2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to veterinary medicine. Summary of the invention consists in the fact that the sick animals are injected with an intravenous doze of lactoglobulin containing 10% of albumins once a day taking into consideration the utilization of 75-80 ml for one-two days, the sick animals are additionaly injected with an intramuscular doze of 100000-150000 ME of retinol once a day for one-three days.The combined activity of the two remedies assures a high effectiveness of the treatment. In this case the immunological reaction of the body reaches a high level, contributing to the suppression of the vital activity of the disease Consequently the exclusion of the utilization of antibiotics contributes to the preservation of the body eubacteriosis and prevents the development of the allergic reactions at people.
MD95-0231A 1995-04-18 1995-04-18 Method of calves bacteriosis treatment MD345G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD95-0231A MD345G2 (en) 1995-04-18 1995-04-18 Method of calves bacteriosis treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD95-0231A MD345G2 (en) 1995-04-18 1995-04-18 Method of calves bacteriosis treatment

Publications (2)

Publication Number Publication Date
MD345F1 MD345F1 (en) 1995-12-31
MD345G2 true MD345G2 (en) 1996-09-30

Family

ID=19738671

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0231A MD345G2 (en) 1995-04-18 1995-04-18 Method of calves bacteriosis treatment

Country Status (1)

Country Link
MD (1) MD345G2 (en)

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Aschaffenburg R., Bartlett S., Kon S.K., Roy G.H.B. and D.M. Walker and G. Briggs and R. Lovell: The nutritive value of colostrum for the calf. 4. The effect of small quantities of colostru whey, dialysed whey and "Immune lactoglobulins". Britt. J. 5: 171-176, 1951. *
Gay C.C., Anderson N., Fisher E.W., Nc Ewan A.D.: Gammaglobulin levels and neonatal mortality in marcet calves. vrt. rec. 77: 148 - 149. *
Mc Ewan A.D., Fisher E.W., Selman I.E., Penhale W.I.: A turbidity test for the estimation of immune globulin levels in neonatal calf serum. clin. chimiea acta. 27: 155-163, 1970. *
Penhale W.J., Logan E.F., Selman I.E., Fisher E.W., Mc Ewan A.D.: Observations on the absorption of colostral immunoglobulins by the neonatal calf and their significance in colibacilosis. am. rech. veter., 4: 223-233, 1973. *
Гутковский А. А., Дворкин С.Л.: Колибактериоз телят и свиней. Минск, "Ураджай", p. 73-96, 1989. *

Also Published As

Publication number Publication date
MD345F1 (en) 1995-12-31

Similar Documents

Publication Publication Date Title
DE69009185D1 (en) MEDICINAL RELEASE SYSTEM FROM GLUCAN AND ADJUVANT.
ATE252899T1 (en) PRODUCTS CONTAINING THYROID HORMONES
DE60038104D1 (en) MEDICINAL PREPARATIONS FOR THE TREATMENT OF ALPHA GALACTOSIDASE A LACK
DE69527966D1 (en) PHARMACEUTICAL PREPARATION FOR SUBCUTANEOUS, INTRAMUSULAR OR INTRADERMAL ADMINISTRATION OF FACTOR VIII
MD345G2 (en) Method of calves bacteriosis treatment
YU61598A (en) Cytokine related treatments of disease
RU2009136424A (en) COMPOSITION AND METHOD FOR TREATING PAPILLOMAVIRUS AND HORSE SARCOIDS
RU95104171A (en) Agent for treatment of immunosuppression at sepsis in human and method of its treatment
GB9216859D0 (en) Medicaments
EP0875251A1 (en) Therapeutic agent and method for feline aids virus infections and feline atopic dermatitis
RU94000695A (en) Agent showing antiallergic action
Stone The possible role of mega-ascorbate in the endogenous synthesis of interferon
SU1072308A1 (en) Antimicrobial composition
ATE107504T1 (en) MEDICATIONS FOR THE TREATMENT OF CRYPTOSPORIDIOSIS.
RU2002104753A (en) Method for the prevention and treatment of cattle leukemia
RU93033105A (en) METHOD FOR THE TREATMENT OF ACUTE VIRAL DISEASES OF ANIMAL ANIMALS OF PSYCHES
RU2031655C1 (en) Remedy for treatment of tonsillitis
Joyce et al. Brain iron delocalization during various methods of artificial perfusion
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound
SU1286208A1 (en) Method of treatment of depressive states
RU94016196A (en) Method for treating the cases of abdominal typhoid
MX2025005287A (en) Compositions and methods using glycine to reduce biological age of an adult animal
UA48539A (en) Method for preventing anemia and oxidation stress in young pigs
Jones et al. Drug overdose patients requiring intensive care admission in the Greater Portland Metropolitan Area: An analysis
Dart et al. Treatment of polonium poisoning with dimercapto chelating agents

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20150418